Advanced Precision Cancer Treatment for Better Outcomes
Cancer treatment has undergone remarkable advancements in recent years. Traditional therapies such as surgery, chemotherapy, and radiation therapy remain important, but modern cancer care now includes highly specialized treatments known as Targeted Therapy and Immunotherapy.
These innovative treatments are designed to attack cancer more precisely, often with fewer side effects than conventional therapies. They have transformed outcomes for many patients with breast cancer, lung cancer, colorectal cancer, melanoma, kidney cancer, and several other malignancies.
Dr. Praveenkumar Surpur works as part of a multidisciplinary cancer care team at Yashodhara Super Speciality Hospital, Solapur, helping patients access advanced cancer treatment options through personalized treatment planning.
Targeted Therapy is a type of cancer treatment that specifically targets certain molecules, proteins, genes, or pathways that help cancer cells grow and survive.
Unlike traditional chemotherapy, which affects many rapidly dividing cells, targeted therapy focuses on specific abnormalities within cancer cells.
This approach is often called Precision Medicine because treatment is tailored according to the biological characteristics of the tumor.


Cancer cells often contain genetic mutations or abnormal proteins that drive their growth.
Targeted therapy works by:
By focusing on specific targets, these treatments can be highly effective in selected patients.
Immunotherapy is an advanced cancer treatment that helps the body’s immune system recognize and destroy cancer cells.
Normally, the immune system identifies and eliminates abnormal cells. However, cancer cells often develop ways to hide from immune defenses.
Immunotherapy helps:
This allows the immune system to fight cancer more effectively.
Cancer cells can create “checkpoints” that prevent immune cells from attacking them.
Immunotherapy works by:
In some patients, immunotherapy produces durable and long-lasting responses.


| Treatment | Primary Action |
|---|---|
| Chemotherapy | Directly kills rapidly dividing cancer cells |
| Targeted Therapy | Attacks specific molecular targets within cancer cells |
| Immunotherapy | Activates the immune system to fight cancer |
Many patients receive a combination of these treatments depending on their cancer type and stage.
Targeted therapy is commonly used for:
Certain breast cancers have specific receptors that respond well to targeted medications.
Targeted therapy has significantly improved outcomes in patients with specific genetic mutations.
Selected advanced colorectal cancers may benefit from targeted treatments.
Some gastric cancers express molecular markers that allow targeted treatment.
Targeted therapies may be recommended in selected patients.
Targeted drugs are commonly used in advanced kidney cancer treatment.
Certain advanced thyroid cancers may respond to targeted therapies.


Immunotherapy has become an important treatment option for:
One of the most common cancers treated with immunotherapy.
Immunotherapy has revolutionized melanoma treatment.
Many patients benefit from immune-based treatment strategies.
Selected patients may receive immunotherapy.
Immunotherapy can improve outcomes in advanced disease.
Specific molecular subtypes respond well to immunotherapy.
Immunotherapy may be used as part of advanced treatment protocols.
Not all cancers are suitable for targeted treatment.
Eligibility depends on:
Specialized laboratory testing is often required before treatment.
Eligibility depends on:
Your oncology team determines whether immunotherapy is appropriate.

Before starting targeted therapy or immunotherapy, doctors often perform advanced testing.
These tests may include:
Identifies mutations driving cancer growth.
Determines whether specific proteins are present.
Evaluates tumor characteristics.
Provides detailed genetic information about cancer cells.

Targeted therapy offers several potential benefits.
Focuses on cancer-specific abnormalities.
Customized according to tumor biology.
May cause fewer side effects compared to traditional chemotherapy.
Can significantly slow disease progression.
Enhances treatment success in selected patients.
Immunotherapy offers unique benefits.
Uses the body’s own defense system.
Some patients experience durable responses.
Can improve survival even in advanced disease.
May be combined with surgery, chemotherapy, radiation therapy, or targeted therapy.
Side effects vary depending on the medication.
Possible side effects include:
Most side effects can be managed effectively with medical supervision.
Because immunotherapy stimulates the immune system, it can occasionally affect healthy organs.
Potential side effects include:
Regular monitoring helps ensure safe treatment.
Successful use of targeted therapy and immunotherapy requires collaboration among specialists.
Treatment planning often involves:
This team-based approach helps identify the most effective treatment strategy.
Patients receiving targeted therapy or immunotherapy undergo regular evaluation.
Monitoring may include:
These evaluations help ensure treatment effectiveness and safety.

Dr. Praveenkumar Surpur provides comprehensive cancer evaluation and multidisciplinary treatment planning to help patients access the most appropriate advanced cancer therapies.
Targeted therapy is a cancer treatment that specifically attacks certain genes, proteins, or pathways responsible for cancer growth.
Immunotherapy helps the body’s immune system recognize and destroy cancer cells more effectively.
Not necessarily. The best treatment depends on cancer type, stage, and molecular characteristics. Many patients benefit from a combination approach.
No. Eligibility depends on cancer type, biomarker testing, and individual patient factors.
They often have different side effect profiles and may be better tolerated in selected patients, but all treatments require careful monitoring.
Molecular and genetic testing helps identify whether the tumor contains specific targets for treatment.
In some patients, immunotherapy can produce long-term disease control and exceptional treatment responses. Outcomes vary depending on the cancer type.
No. Targeted therapy and immunotherapy may be used in early-stage, locally advanced, or metastatic cancers depending on clinical circumstances.
Some are given intravenously, while others are available as oral medications.
Dr. Praveenkumar Surpur provides comprehensive cancer evaluation and multidisciplinary treatment planning at Yashodhara Super Speciality Hospital, Solapur, helping patients access advanced treatment options including Targeted Therapy and Immunotherapy.
Disclaimer: Results and patient experiences may vary. These are dependent on a number of factors including age, medical history, lifestyle and more.
Consult Dr. Praveenkumar Surpur for advanced cancer treatment planning in Solapur and receive personalized guidance regarding the latest treatment options available for your cancer type.
Yashodhara Super Speciality Hospital, Solapur
Call Now to Schedule Your Consultation
WhatsApp us
